Clear Air tablets are a modern oral medication containing the active ingredient montelukast at a concentration of 10 mg per tablet. Montelukast belongs to an important class of medications called leukotriene receptor antagonists. Leukotrienes play a key role in the symptoms of asthma and allergic rhinitis by constricting the airways and increasing mucus production and inflammation. Clear Air works effectively by blocking the effects of these chemicals in the body, helping to prevent and treat chronic asthma and relieve the bothersome symptoms associated with seasonal and perennial allergic rhinitis. Clear Air is an essential part of the long-term treatment plan for these common respiratory conditions, helping to improve patients' quality of life and reduce the need for other medications used to relieve acute symptoms.
The active ingredient in Clear Air tablets
Each Clear Air tablet contains the following active ingredient, which is the basis of its therapeutic effect in controlling asthma and allergic rhinitis:
Montelukast: A chemical compound that acts as a selective antagonist of leukotriene CysLT1 receptors found in the airways and other cells in the body that play a role in allergic inflammation. Leukotrienes, including leukotriene D4, are released by immune cells in response to allergens or other irritants. The binding of these leukotrienes to their receptors leads to narrowing of the airways, increased mucus secretion, and inflammation, which are the main symptoms of asthma and allergic rhinitis. Montelukast works by blocking the binding of leukotrienes to these receptors, thereby helping to widen the airways, reduce mucus production, and relieve inflammation, significantly improving the symptoms of asthma and allergic rhinitis.
Available Strengths
Clear Air tablets are typically available in one strength suitable for use in adults and adolescents aged 15 years and older:
10 mg: This strength is the standard dosage for adults and adolescents for the treatment of asthma and allergic rhinitis.
In addition to 10 mg tablets, other dosage forms of montelukast are available in lower strengths and forms suitable for younger children, such as chewable tablets and oral granule sachets. The appropriate dosage and dosage form are determined by the physician based on the patient's age, weight, and the type and severity of the condition. One 10 mg Clear Air tablet is usually taken once daily in the evening for the treatment of asthma and allergic rhinitis. For the prevention of exercise-induced bronchoconstriction, a single dose should be taken at least two hours before exercise. It is important to strictly follow the physician's instructions regarding the dosage and timing of the medication.
Indications for Use of Clear Air Tablets
Clear Air tablets are primarily used for the following conditions related to asthma and allergic rhinitis:
Prevention and treatment of chronic asthma: Clear Air is used as a long-term preventative treatment to help control asthma symptoms and reduce the frequency of asthma attacks. It is not used to treat acute asthma attacks.
Relief from symptoms of seasonal and perennial nasal allergies (allergic rhinitis): Clear Air helps relieve symptoms associated with nasal allergies, such as a runny nose, blocked nose, sneezing, and itchy nose and eyes. It can be used for both seasonal allergies (such as hay fever) and perennial allergies (caused by dust mites or animal dander).
Prevention of exercise-induced bronchoconstriction (EIB): Clear Air can be used to help prevent the narrowing of the airways that occurs in some people during or after exercise.